




版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
CasestudyMr.Wongisa48-yearoldmale,salesrepresentativewhotravelsoften170cm,84kg,BMI29HisbrotherjustsufferedfromMIatage40.ConcernedabouthishealthWanttodostartexerciseandloseweightCasestudyMr.Wongisa48-yea1EvaluationClassifyclientaccordingtoRiskStratificationCriteriaACSM/ACP/ACCVPR/AHAIdentifyMajorCoronaryArteryDiseaseRiskFactorsIdentifysignsorsymptomssuggestiveofcardiopulmonarydiseaseIdentifysecondaryriskfactorsObesity,alcoholconsumption,stresslevelsEvaluationClassifyclientacco2CaseStudyRecentlydiagnosedtohavetype2DM,putonDaonilBP160/90mmHgonmetoprolol50mgbdHalfpackadaysmokinghabitduetostressofhisjobHisbrotherjustsufferedfromMIatage40.Cholesterollevel:6.2mmol/l,HDL0.90mmol/l,LDL3.8mmol/lTG:2.4mmol/lNoregularexerciseNosignsorsymptomsofcardiopulmonarydiseaseCaseStudyRecentlydiagnosedt3【高血壓英文課件】Positive-Risk-Factors-for-CHD4【高血壓英文課件】Positive-Risk-Factors-for-CHD5InitialRiskStratificationLowriskMen<45yearsofageandwomen<55yearsofageYoungerindividualswhoareasymptomaticandmeetnomorethanoneriskfactorthresholdModerateriskOlderindividuals(men45yearsofage;women55yearsofage)orthosewhomeetthethresholdfortwoormoreriskfactorsHighRiskIndividualswithoneormoresigns/symptomsorknowncardiovascular,pulmonary,ormetabolicdiseaseInitialRiskStratificationLow6Whatrecommendationsinreferencetomedicalexaminationandtestingpriortoparticipationinanexerciseprogram?A.MedicalexaminationandexercisetestingB.PhysicianSupervisionofexercisetestWhatrecommendationsinrefere7Considerthefollowingcriteriaduringyourevaluation:AgeandgenderModerateVsvigorousexerciseprogramPhysicianpresentduringtestingSubmaximalormaximalgradedexercisetestTypeoftest(treadmill,legergometer,step)AbsoluteandrelativecontraindicationstoexercisetestingConsiderthefollowingcriteri8ACSMRecommendationsfor:Pre-participationscreeningAlgorithmACSMRecommendationsfor:Pre-9ACSMRecommendationsfor:Pre-participationscreeningAlgorithmcont’ACSMRecommendationsfor:Pre-10CardiovascularSystemAssessment Agradedexercisetestmaybehelpfulifapatient,abouttoembarkonamoderatetohigh-intensityphysicalactivityprogram,isathighriskforunderlyingcardiovasculardisease,basedononeofthefollowingcriteria:Age>40years,+/-CVDriskfactorsAge>30yearsandType1or2diabetesof>10years'durationPresenceofanyadditionalriskfactorforcoronaryarterydiseasePresenceofmicrovasculardisease(proliferativeretinopathyornephropathy,includingmicroalbuminuria)PeripheralvasculardiseaseAutonomicneuropathyCardiovascularSystemAssessme11MedicationsMedications12Aconstellationofcardiovascularriskfactorsrelatedtohypertension,abdominalobesity,dyslipidemia,andinsulinresistanceCertaindrugsusedtotreathypertensionmayacceleratetheappearanceofnew-onsetdiabetes.Inparticular,bothβblockersanddiureticshavebeenimplicatedinthiseffect.MetabolicSyndromeAconstellationofcardiovascu13ALLHATInhighriskhypertensivepatients,thediuretic,chlorthalidone,was43%morelikelythantheACEI,lisinopril,toproducediabetes,butwasalso18%morelikelythanthecalciumchannelblocker,amlodipine,toproducethisadverseeffect.HOPEThedevelopmentofnewdiabeteswasreducedby34%(p<0.001)intheramipril-treatedgroup.LIFE(LosartanInterventionForEndpointReductioninHypertension)TheARB,losartan,wasassociatedwitha25%relativeriskreductioninnew-onsetdiabeteswhencomparedwiththeβblocker,atenololVALUE
(TheValsartanAntihypertensiveLong-termUseEvaluation)Valsartan,wasassociatedwith23%RRRinnew-onsetdiabeteswhencomparedwiththecalciumchannelblocker,amlodipine.【高血壓英文課件】Positive-Risk-Factors-for-CHD14ARB/ACEImayhavepositiveeffectsoninsulinactionandpotentiallyplaysameaningfulroleinprotectinghigh-riskhypertensivepatientsfromdevelopingdiabetes.ARB/ACEImayhavepositiveef15MedicationsMetoprololchangedtoACEinhibitors/ARBMetforminStatinMedicationsMetoprololchanged16ExercisestresstestMETSachieved:8.5Peakheartrate:165beatsperminutePeakbloodpressureof200/88mmHg.NoexerciseinducedischemiaExercisestresstestMETSachie17QuestionsPleasewriteaninitialexerciseprescriptionAnyadjustmentsandpracticaltipsinpatientswithDMandHT?QuestionsPleasewriteaniniti18ExerciseprescriptionAddresseachofthefollowingAerobicenduranceStrengthtrainingFlexibilityIncludeeachofthefollowinginyourprescription frequency times/day,days/week Intesnisy 5HRR,%VO2max,%HRmax,%1RM,%MVC,etc Duration warm-up,cool-down,exercisecomponent,restbetweensets,etc Modeofexercise typesofexerciise,stretchingtechniques,resistancetraining,etc Rateofprogression
ExerciseprescriptionAddresse19ACSMandCDCRecommendationAmericanCollegeofSportsMedicine(ACSM)andCentersforDiseaseControlandPrevention(CDC),1995(Pateetal.,1995)Recommendation:Everyadultshouldengageinmoderate-intensityphysicalactivityfor30minutesorlongeronmost,preferablyall,daysoftheweek.Moderateintensityisdefinedas40to60%ofmaximaloxygenconsumption(VO2max).The30-minuteactivitycanalsoconsistofshorterexercisebouts(minimumof10minutes)thatareaccumulatedthroughouttheday(e.g.,walkingtowork,shopping).FinnishMedicalSocietyDuodecim.Physicalactivityintheprevention,treatmentandrehabilitationofdiseases.2004Apr20ACSMandCDCRecommendationAme20ACSMRecommendationforHypertension40-70%ofVO2max,i.e.55-80%ofthemaximalheartrate.Thelowerrangeofintensityissufficientfortheelderly.3or4timesweeklyforatleast30minutesatatimeVariousenduranceexercisemodesaresuitable.Resistancetraining(preferablycircuittraining)shouldnotbetheonlyformofexercisebutshouldbecombinedwithendurancetraining.Trainingatanintensityofabout50%ofthemaximalexerciseperformance(moderate-intensity)issufficientwithregardtorestingbloodpressurereduction(Fagard,2001).FinnishMedicalSocietyDuodecim.Physicalactivityintheprevention,treatmentandrehabilitationofdiseases.2004Apr20ACSMRecommendationforHypert21RehabilitationinCoronaryHeartDisease
Mainlyendurancetraining
atanintensityof50(-60)-75%ofsymptom-limitedVO2max(orheartratereserve,whichisthedifferencebetweenmaximalandrestingheartrate)for30minutes3-4timesweekly(minimum),fullbenefitisobtainedwith5-6times/weekResistancetraininginadditionatanintensityof30-50%(upto60-80%)of1RM(onerepetitionmaximum),12-15repetitions,1-3setstwiceweeklyRehabilitationinCoronaryHea22RecommendationsforPatientsWithType2Diabetes Exerciseprogram:
Type:AerobicIntensity:50-70%ofmaximumaerobiccapacityDuration:20-60minutesFrequency:3-5timesperweekAvoidcomplicationsWarmupandcooldownCarefulselectionofexercisetypeandintensityPatienteducationMonitoringofbloodglucosebypatientandoverallprogrambymedicalpersonnel
PhysicalActivity/ExerciseandDiabetes;Diabetescare,vol.27,supplement1,January2004RecommendationsforPatientsW23RecommendationsforPatientsWithType2Diabetes3. Compliance:MakeexerciseenjoyableConvenientlocationPositivefeedbackfrominvolvedmedicalpersonnelandfamilyPhysicalActivity/ExerciseandDiabetes;Diabetescare,vol.27,supplement1,January2004RecommendationsforPatientsW24..25HypertensionMonit
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- T-ZHAQ 6-2024 帶逆變輸出的儲(chǔ)能電源
- 醫(yī)院與醫(yī)學(xué)檢驗(yàn)技術(shù)人員2025年度勞動(dòng)合同
- 二零二五年度股權(quán)質(zhì)押與企業(yè)債務(wù)重組合同
- 二零二五年度集體宿舍租賃與社區(qū)治理服務(wù)合同
- 全面履行原則在2025年度房地產(chǎn)項(xiàng)目開(kāi)發(fā)合同中的執(zhí)行要求
- 二零二五年度汽車(chē)運(yùn)輸安全責(zé)任保險(xiǎn)合作協(xié)議
- 二零二五年度文化展覽聘請(qǐng)藝術(shù)藝人演出合同
- 2025年度高科技研發(fā)項(xiàng)目投資債轉(zhuǎn)股協(xié)議書(shū)
- 2025年度新能源汽車(chē)產(chǎn)業(yè)鏈債權(quán)轉(zhuǎn)讓合同
- 二零二五年度電子元器件制造勞務(wù)派遣員工合同
- 重慶市南開(kāi)名校2024-2025學(xué)年八年級(jí)下學(xué)期開(kāi)學(xué)考試物理試題(含答案)
- 滲漉法胡鵬講解
- 2025年交管12123學(xué)法減分試題庫(kù)附參考答案
- 2025年360億方智能航空AI白皮書(shū)-愛(ài)分析
- 【道 法】學(xué)會(huì)自我保護(hù)+課件-2024-2025學(xué)年統(tǒng)編版道德與法治七年級(jí)下冊(cè)
- 事業(yè)編 合同范例
- 福建省廈門(mén)市第一中學(xué)2023-2024學(xué)年高二上學(xué)期開(kāi)學(xué)考試英語(yǔ)試題(解析版)
- 2025屆高考英語(yǔ)讀后續(xù)寫(xiě)提分技巧+講義
- 買(mǎi)房協(xié)議書(shū)樣板電子版
- 2024年無(wú)錫科技職業(yè)學(xué)院高職單招數(shù)學(xué)歷年參考題庫(kù)含答案解析
- 2025年山東新華書(shū)店集團(tuán)限公司臨沂市縣分公司招聘錄取人員高頻重點(diǎn)提升(共500題)附帶答案詳解
評(píng)論
0/150
提交評(píng)論